Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
JTC
JEMTEC
C$0.85
-1.2%
C$0.87
C$0.63
C$1.00
C$2.37M0.385,061 shs5,500 shs
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$28.94
+1.1%
$27.44
$23.69
$31.72
$12.69B0.68796,490 shs298,505 shs
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
JTC
JEMTEC
0.00%0.00%0.00%+2.38%+38.71%
Smith & Nephew plc stock logo
SNN
Smith & Nephew
0.00%-1.51%+7.50%+1.99%+15.20%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
JTC
JEMTEC
N/AN/AN/AN/AN/AN/AN/AN/A
Smith & Nephew plc stock logo
SNN
Smith & Nephew
2.495 of 5 stars
1.03.02.50.04.20.03.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
JTC
JEMTEC
0.00
N/AN/AN/A
Smith & Nephew plc stock logo
SNN
Smith & Nephew
2.00
Hold$28.00-3.23% Downside

Current Analyst Ratings Breakdown

Latest ANII, BHMU, SNN, and JTC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/1/2025
Smith & Nephew plc stock logo
SNN
Smith & Nephew
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$27.00 ➝ $28.00
4/25/2025
Smith & Nephew plc stock logo
SNN
Smith & Nephew
Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
4/25/2025
Smith & Nephew plc stock logo
SNN
Smith & Nephew
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Hold
3/17/2025
Smith & Nephew plc stock logo
SNN
Smith & Nephew
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold$27.00 ➝ $27.00
3/12/2025
Smith & Nephew plc stock logo
SNN
Smith & Nephew
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeBuy ➝ Neutral
(Data available from 5/27/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
JTC
JEMTEC
C$1.59M1.49C$0.47 per share1.80C$0.84 per share1.01
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$5.81B2.18$3.62 per share8.00$11.94 per share2.42
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
JTC
JEMTEC
N/AC$0.0242.50N/A2.74%1.87%2.06%N/A
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$263M$2.1613.4114.471.26N/AN/AN/A8/5/2025 (Estimated)
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
JTC
JEMTEC
N/A7.14%N/AN/AN/A
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$0.893.08%N/A41.20%N/A

Latest ANII, BHMU, SNN, and JTC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/3/2025
JTC
JEMTEC
specialC$0.054/11/20254/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
JTC
JEMTEC
0.40
11.95
14.45
Smith & Nephew plc stock logo
SNN
Smith & Nephew
0.63
2.51
1.11

Institutional Ownership

CompanyInstitutional Ownership
JTC
JEMTEC
N/A
Smith & Nephew plc stock logo
SNN
Smith & Nephew
25.64%

Insider Ownership

CompanyInsider Ownership
JTC
JEMTEC
50.14%
Smith & Nephew plc stock logo
SNN
Smith & Nephew
1.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
JTC
JEMTEC
N/A2.79 millionN/ANot Optionable
Smith & Nephew plc stock logo
SNN
Smith & Nephew
20,100437.96 million432.83 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

JEMTEC CVE:JTC

C$0.85 -0.01 (-1.16%)
As of 10:58 AM Eastern

JEMTEC Inc. provides integrated technology systems for community-based corrections in Canada. It offers services and technologies for offender monitoring in Canadian federal and provincial correctional departments. The company also provides various levels of technology, which allows corrections, courts, and police to select from various options ensuring the correct level of offender control. n addition, its offender location detection/verification technologies include offender reporting through telephone contact, offender reporting kiosks with integrated database, global positioning system active and passive tracking, voice verification, electronic monitoring house arrest systems, remote alcohol in-home monitoring, and private monitoring services. JEMTEC Inc. was incorporated in 1981 and is headquartered in North Vancouver, Canada.

Smith & Nephew stock logo

Smith & Nephew NYSE:SNN

$28.94 +0.31 (+1.07%)
As of 02:43 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.